David Cooper
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
- Epidemiology top 2%
- Pneumonia and Respiratory Infections
- Respiratory viral infections research
Papers in
- Epidemiology 36
- Respiratory viral infections research 21
- Pneumonia and Respiratory Infections 8
- Virology and Viral Diseases 5
-
- SARS-CoV-2 and COVID-19 Research 8
- Antimicrobial Resistance in Staphylococcus 6
- Co-authors
- Kathrin U. Jansen (17 shared papers)Kena A. Swanson (21 shared papers)Philip R. Dormitzer (10 shared papers)Mark Cutler (9 shared papers)Pei‐Yong Shi (7 shared papers)Xuping Xie (7 shared papers)Jing Zou (7 shared papers)Hongjie Xia (6 shared papers)
- Journals
- Open Forum Infectious Diseases (9 papers)Vaccine (9 papers)Human Vaccines & Immunotherapeutics (5 papers)The Journal of Infectious Diseases (5 papers)Journal of Virology (4 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
David Cooper
53 papers receiving 2.3k citations
David Cooper's Hit Papers
Peers
Comparison fields: 5 of 102
- Infectious Diseases 1.2k
- Epidemiology 789
- Microbiology 146
- Animal Science and Zoology 194
- Virology 73
Countries citing papers authored by David Cooper
This map shows the geographic impact of David Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cooper more than expected).
Fields of papers citing papers by David Cooper
This network shows the impact of papers produced by David Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cooper. The network helps show where David Cooper may publish in the future.
Co-authors
The 25 scholars most cited alongside David Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera Hit paper breakdown → | 2021 | 385 |
| 2 | BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants Hit paper breakdown → | 2021 | 212 |
| 3 | 2011 | 193 | |
| 4 | 1983 | 136 | |
| 5 | 2016 | 119 | |
| 6 | 2013 | 100 | |
| 7 | 2012 | 83 | |
| 8 | 2007 | 73 | |
| 9 | 2006 | 73 | |
| 10 | 2021 | 72 | |
| 11 | 1991 | 68 | |
| 12 | 2022 | 65 | |
| 13 | 2017 | 60 | |
| 14 | 2021 | 59 | |
| 15 | 2006 | 57 | |
| 16 | 2015 | 51 | |
| 17 | 2016 | 44 | |
| 18 | 2022 | 42 | |
| 19 | 2015 | 37 | |
| 20 | 2021 | 34 |
About David Cooper
David Cooper is a scholar working on Epidemiology, Infectious Diseases, Animal Science and Zoology, Genetics and Molecular Biology, having authored 57 papers that have together received 2.4k indexed citations. Recurring topics across this work include Respiratory viral infections research (21 papers), Pneumonia and Respiratory Infections (8 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Animal Virus Infections Studies (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Virus-based gene therapy research (6 papers), Virology and Viral Diseases (5 papers) and Bacterial Infections and Vaccines (5 papers). The work is most often cited by research in Infectious Diseases (1.2k citations), Epidemiology (789 citations), Microbiology (146 citations), Animal Science and Zoology (194 citations) and Virology (73 citations). David Cooper has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Kathrin U. Jansen, Kena A. Swanson, Philip R. Dormitzer, Mark Cutler, Pei‐Yong Shi, Xuping Xie, Jing Zou, Hongjie Xia, Annaliesa S. Anderson and Kathrin U. Jansen. Their work appears in journals such as Open Forum Infectious Diseases, Vaccine, Human Vaccines & Immunotherapeutics, The Journal of Infectious Diseases and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.